| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 01/31/2002 | WO2002008176A1 Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for the production thereof |
| 01/31/2002 | WO2001070682A3 Carbocyclic side chain containing metalloprotease inhibitors |
| 01/31/2002 | US20020013496 Benzene compounds as antiproliferative and cholesterol lowering agents |
| 01/31/2002 | US20020013381 Ionic compounds with delocalized anionic charge, and their use as ion conducting components or as catalysts |
| 01/30/2002 | EP1176139A1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 01/30/2002 | EP1175383A1 Glucocorticoid receptor modulators |
| 01/30/2002 | EP0934267B1 Alpha-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors |
| 01/30/2002 | EP0922043B1 Pesticidal 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazoles |
| 01/30/2002 | CN1078589C 4-jod-2-[N-(N-alkyl-aminocarbonyl)-aminocarbonyl)-aminosulfonyl]-benzoic acid methyl ester and derivatived thereof and method for their |
| 01/30/2002 | CN1078588C The preparation of substituted guanidine derivatives |
| 01/29/2002 | US6342630 Chemical process |
| 01/29/2002 | US6342512 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals |
| 01/29/2002 | CA2145296C Benzenealkanoic acids for cardiovascular diseases |
| 01/24/2002 | WO2002006190A2 Crystalline and salt forms of an hiv protease inhibitor |
| 01/24/2002 | WO2002006189A2 Aniline derivatives |
| 01/24/2002 | WO2002005954A1 Composition and compound based on metal and acid salt(s) having a sulphonyl group borne by a perhalogenated carbon and their use as lewis acid |
| 01/24/2002 | US20020010085 Hydrogenation catalyst |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/24/2002 | US20020009635 Novel materials for use as electrolytic solutes |
| 01/23/2002 | EP1174426A1 Method for the preparation of tricyclic amino alcohol derivatives through azides |
| 01/23/2002 | EP1174425A1 Novel method for manufacturing tricyclic amino alcohol derivatives |
| 01/23/2002 | EP1174421A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 01/23/2002 | EP1174417A1 Fluorine compounds and water- and oil-repellant compositions |
| 01/23/2002 | EP1174028A1 Sulfonamide derivatives |
| 01/23/2002 | EP1173161A2 Glucamine compounds for treating hepatitis virus infections |
| 01/23/2002 | CN1332734A Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity |
| 01/23/2002 | CN1332724A N-arylsulfonyl amino acid omega amides |
| 01/22/2002 | US6340716 Electrodes, conductors, capacitors and batteries |
| 01/22/2002 | CA2024956C Isoxazoles herbicides |
| 01/17/2002 | WO2002004412A2 Tyrosine derivatives as phosphatase inhibitors |
| 01/17/2002 | WO2002004407A2 7-substituted tetracycline compounds |
| 01/17/2002 | WO2002004406A2 9-substituted minocycline compounds |
| 01/17/2002 | WO2002003995A2 Treatment of male sexual dysfunction |
| 01/17/2002 | WO2001046125A3 Cd45 inhibitors |
| 01/17/2002 | WO2000071493A3 INHIBITORS OF FACTOR Xa |
| 01/17/2002 | US20020007083 Sulfonated perfluorovinyl functional monomers |
| 01/17/2002 | US20020006957 Method for the synthesis of compounds of formula I and their uses thereof |
| 01/17/2002 | DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments |
| 01/17/2002 | CA2414112A1 Treatment of male sexual dysfunction |
| 01/16/2002 | EP1171422A1 Mmp inhibitor |
| 01/16/2002 | CN1331674A Sulfonamide hydroxamates |
| 01/16/2002 | CN1077885C Biphenylsulfonamide matrix metalloproteinase inhibitors |
| 01/10/2002 | WO2002002520A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002517A1 Acylsulfonamide derivatives |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002101A1 Hypoglycemics |
| 01/10/2002 | US20020004613 Reacting a sulphonyl halide with nucleophilic base |
| 01/10/2002 | DE10032138A1 Verwendung von Eisen-Azokomplexverbindungen als Ladungssteuermittel Use of iron-Azokomplexverbindungen as charge control agents |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170287A1 Process for preparation of optically active n-substituted azetidine-2-carboxylic acids |
| 01/09/2002 | EP1169031A1 Antimicrobial agents |
| 01/09/2002 | EP0858447B1 Methods of producing aminophenylsulphonyl carbamides and intermediate products for use in the process |
| 01/09/2002 | CN1330593A Heat sensitive recording material |
| 01/09/2002 | CN1077569C The preparatin of substituted guanidine derivative |
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/03/2002 | WO2002000622A2 Aminoalcohol derivatives |
| 01/03/2002 | WO2002000606A1 Biphenyl compound |
| 01/03/2002 | WO2002000167A2 Modified forms of pharmacologically active agents and uses therefor |
| 01/03/2002 | US20020002183 Benzamides and related inhibitors of factor Xa |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | CA2414150A1 Modified forms of nonsteroidal anti-inflammatory drugs and uses thereof |
| 01/02/2002 | EP1168090A1 Use of iron-azo complex compositions as charge control agents |
| 01/02/2002 | EP1166773A1 Solution of N- O(p-pivaloyloxbenzenesulfonylamino)benzoyl glycine monosodium salt tetra-hydrate and drug product thereof |
| 01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
| 01/02/2002 | EP1165504A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 01/02/2002 | EP1165502A1 Diaryl derivatives and their use as medicaments |
| 01/02/2002 | EP1165501A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 01/02/2002 | EP1165495A1 Resorcinol derivatives |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 01/02/2002 | EP0706518B1 Acylated aminophenyl urea compounds, their preparation and their use as herbicides and plant-growth regulators |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/01/2002 | US6335467 Intermediates for antiarrhythmia agents |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | US6335333 Matrix metalloproteinase inhibitors |
| 01/01/2002 | US6335303 Effective in polymerization of alpha olefins to high molecular weight polymers |
| 01/01/2002 | CA2351953A1 Use of iron azo complex compounds as charge control agents |
| 12/27/2001 | WO2001098274A2 Sulphonamide derivatives |
| 12/27/2001 | WO2001098264A1 Macrophage scavenger receptor antagonists |
| 12/27/2001 | WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 12/27/2001 | WO2001098248A2 Hiv integrase inhibitors |
| 12/27/2001 | US20010056185 C3A receptor ligands |
| 12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 12/27/2001 | US20010056088 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors |
| 12/27/2001 | CA2412985A1 Hiv integrase inhibitors |
| 12/26/2001 | CN1328545A Hydrazine derivatives |
| 12/26/2001 | CN1328453A Pharmaceutical composition comprising combination of dextro-and laevo-isomers of sotalol |
| 12/26/2001 | CN1327981A Amidine compound and its preparing process |
| 12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
| 12/25/2001 | US6333358 Aryloxyaniline derivatives |
| 12/25/2001 | US6333349 Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them |
| 12/25/2001 | US6333337 Potassium channel inhibitors |
| 12/20/2001 | WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |